[
  {
    "ts": "2025-11-26T02:12:09+00:00",
    "headline": "Regeneron Pharmaceuticals (REGN): Examining Valuation After Recent Share Price Momentum",
    "summary": "Regeneron Pharmaceuticals (REGN) shares have shown steady gains over the past month, supported by the company’s consistent revenue and net income growth. Investors are keeping an eye on how Regeneron continues to execute on its existing strengths. See our latest analysis for Regeneron Pharmaceuticals. Regeneron’s impressive 36% one-month share price return has given it real momentum, especially when you consider its steady gains earlier in the year. Over a five-year period, its total...",
    "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-regn-examining-valuation-021209029.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "40980dc4-614b-3da8-8422-3e595afd2899",
      "content": {
        "id": "40980dc4-614b-3da8-8422-3e595afd2899",
        "contentType": "STORY",
        "title": "Regeneron Pharmaceuticals (REGN): Examining Valuation After Recent Share Price Momentum",
        "description": "",
        "summary": "Regeneron Pharmaceuticals (REGN) shares have shown steady gains over the past month, supported by the company’s consistent revenue and net income growth. Investors are keeping an eye on how Regeneron continues to execute on its existing strengths. See our latest analysis for Regeneron Pharmaceuticals. Regeneron’s impressive 36% one-month share price return has given it real momentum, especially when you consider its steady gains earlier in the year. Over a five-year period, its total...",
        "pubDate": "2025-11-26T02:12:09Z",
        "displayTime": "2025-11-26T02:12:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w30LARiR1Z35GusfaFi.2g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3eDp_RSETU8kXm3usDK_gQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-regn-examining-valuation-021209029.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-regn-examining-valuation-021209029.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]